Company news

Entropy Neurodynamics Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Preclinical Data from Osteoarthritis Animal Study

April 1, 2021

Appendix 4D and Half Year Financial Report

February 25, 2021

Response to ASX Price and Volume Query

February 8, 2021

Quarterly Report and Appendix 4C

January 28, 2021

September Quarterly Report and Appendix 4C

October 26, 2020

Exopharm raises $10m in well supported Placement

August 26, 2020

Appendix 4E and Annual Financial Report FY 2020

August 26, 2020

June Quarterly Report and Appendix 4C

July 30, 2020

Added IP empowers Exopharms engineered exosome pipeline

June 11, 2020

Shareholder Update

May 27, 2020

Plexaris product engineered to deliver anti-cancer drug

May 24, 2020

March Quarterly Report and Appendix 4C

April 24, 2020

PLEXOVAL I study disrupted by the Covid-19 response

March 31, 2020

Appendix 4D and Interim Financial Report

February 20, 2020

Cevaris testing shows positive results in bladder control

February 19, 2020

Cevaris testing shows positive results in models of ED

February 18, 2020

Independent Plexaris and Cevaris testing

February 11, 2020

December Quarterly Report and Appendix 4C

January 28, 2020

First Dosing in PLEXOVAL Exosome Wound Healing Human Study

January 28, 2020

Key Management Contracts Extended

November 25, 2019

Development Program Update

November 13, 2019

Appointment of Chief Commercial Officer

October 27, 2019

Appendix 4C - quarterly

October 24, 2019

Appendix 4E and Annual Financial Report FY 2019

August 30, 2019

PLEXOVAL Exosome Wound Healing Human Study Starts

August 25, 2019

Share Purchase Plan 2019 Offer Document

July 25, 2019

Share Placement and Share Purchase Plan Announced

July 23, 2019

Securures Ethics Approval for Plexoval Clinical Trial

July 22, 2019

Market Update

March 31, 2019

Explainer The critical bottleneck of exosome isolation

March 26, 2019

Appendix 4D and Interim Financial Report - Dec 18 Half Year

February 21, 2019

Positive outcomes in first animal study involving Plexaris

February 4, 2019

December 2018 Quarterly Cash Flow Report

January 30, 2019

December 2018 Quarterly Activities Report

January 30, 2019

← Newer news releases

Decks

The 5 newest of 7 decks. Every deck is listed under its year.